A Villano Selected Research

Percutaneous Coronary Intervention

10/2018

Microvascular ischemia in patients with successful percutaneous coronary intervention: effects of ranolazine and isosorbide-5-mononitrate.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

A Villano Research Topics

Disease

1	COVID-19 01/2021
1	Hyperlipidemias (Hyperlipidemia) 01/2021
1	Neuromuscular Diseases (Neuromuscular Disease) 01/2020
1	Left Ventricular Dysfunction 01/2020
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2020
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2020
1	Chest Pain (Chest Pains) 01/2019
1	Pathologic Constriction (Stenosis) 10/2018
1	Ischemia 10/2018
1	Myocardial Ischemia (Ischemic Heart Diseases) 10/2018
1	Coronary Stenosis (Coronary Artery Stenosis) 10/2018
1	Stable Angina 10/2018

Drug/Important Bio-Agent (IBA)

1	Antiviral Agents (Antivirals)IBA 01/2021
1	InterferonsIBA 01/2021
1	PCSK9 InhibitorsIBA 01/2021
1	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2020
1	DystrophinIBA 01/2020
1	Troponin T (Troponin T1)IBA 01/2019
1	Ranolazine FDA Link 10/2018
1	isosorbide-5-mononitrate (Ismo)FDA LinkGeneric 10/2018

Therapy/Procedure

1	Percutaneous Coronary Intervention 10/2018
1	Drug-Eluting Stents 10/2018